Sanofi Share News (SAN.PA)

Three-way split coming at BoE

STOXX down 0.4%, volatility hits 1-mo high

*

What to prefer in 2023: Europe or America?

STOXX down 0.4%, volatility hits 1-mo high

*

Europe seen weaker as more rate hikes loom

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

Hunkering down

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

European shares fall for fourth day on growth worries

STOXX 600 falls for the fourth straight day

*

GSK, Sanofi shares soar as Zantac litigation fears abate

Thousands of Zantac lawsuits dismissed on Tuesday

*

Winter is coming... and so are earnings downgrades

STOXX 600 falls 0.5%

*

Being bearish but also bullish on Europe Inc

STOXX 600 down 0.5%

*

Forza Italia in early Europe

STOXX 600 down 0.2%

*

Sanofi shares rally as company avoids U.S. lawsuits over Zantac

PARIS, Dec 7 (Reuters) - Sanofi shares rose by around 8% in early Paris stockmarket trading on Wednesday after the company avoided thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.

GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link

Dec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.

GSK, Pfizer, Sanofi escape U.S. federal litigation over Zantac

Dec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday defeated thousands of lawsuits in U.S. federal court claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.

Europe's STOXX 600 slips, but marks seventh week of gains

Sanofi slips amid Horizon deal talks

*

Sanofi says any offer for Horizon Therapeutics, if made, will be in cash

PARIS, Dec 2 (Reuters) - French drugmaker Sanofi said on Friday that if it decides to bid for biotech company Horizon Therapeutics Plc, it would do so in cash.

Sanofi, GSK score late win with EU COVID booster approval

Nov 10 (Reuters) - Sanofi said on Thursday it won European Union approval for its COVID-19 vaccine booster, jointly made with British partner GSK, after a drawn-out development effort that saw the pair fall behind now-dominant vaccine suppliers.